Not applicableStudy completedNCT06463639What this trial is testingFLT3 Clonal Evolution in Patients With Acute Myeloid LeukemiaWho this might be right forAcute Myeloid Leukemia National Taiwan University Hospital 1,213
Not applicableLooking for participantsNCT06785077What this trial is testingGenetic Landscape in Women with Metastatic Ovarian Cancer Before and During Treatment with PARP InhibitorsWho this might be right forLeukemia, Myeloid, AcuteMyeloid DysplasiaOvarian Epithelial Cancer European Institute of Oncology 157
Not applicableStudy completedNCT02620254What this trial is testingMast Cell Connect: A Registry for Patients With MastocytosisWho this might be right forMastocytosis Blueprint Medicines Corporation 743
Not applicableLooking for participantsNCT07675967What this trial is testingClonal Hematopoiesis Chemotherapy and Radiation Effects StudyWho this might be right forLung Cancer (Diagnosis)OsteochondromaSpitz Nevus+14 more Dana-Farber Cancer Institute 5,000
Testing effectiveness (Phase 2)Study completedNCT01807598What this trial is testingBrentuximab Vedotin in Treating Patients With Advanced Systemic Mastocytosis or Mast Cell LeukemiaWho this might be right forAggressive Systemic MastocytosisMast Cell LeukemiaSystemic Mastocytosis Jason Robert Gotlib 10
Not applicableActive Not RecruitingNCT03918655What this trial is testingMIF Involvement in AMLWho this might be right forAcute Myeloid Leukemia Assistance Publique - Hôpitaux de Paris 186
Testing effectiveness (Phase 2)Looking for participantsNCT03418038What this trial is testingAscorbic Acid and Chemotherapy for the Treatment of Relapsed or Refractory Lymphoma, CCUS, and Chronic Myelomonocytic LeukemiaWho this might be right forClonal Cytopenia of Undetermined SignificanceHigh Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 RearrangementsRecurrent Diffuse Large B-Cell Lymphoma+5 more Mayo Clinic 80
Not applicableLooking for participantsNCT06764459What this trial is testingMolecular Characterization of Patients With Acute Myeloid Leukemia and the Impact of Clonal Evolution in the Response to Therapeutic TreatmentsWho this might be right forMyeloid Leukemia, Acute IRCCS Azienda Ospedaliero-Universitaria di Bologna 20
Not applicableLooking for participantsNCT07500441What this trial is testingDigital PCR of CHIP and MR for MRD Monitoring After Allo-HSCT in AMLWho this might be right forAcute Myeloid Leukemia (AML) Peking University People's Hospital 100
Not applicableNot Yet RecruitingNCT05969821What this trial is testingClonal Hematopoiesis of Immunological SignificanceWho this might be right forImmune System DiseasesAutoimmune DiseasesInflammation+13 more Assistance Publique - Hôpitaux de Paris 5,000
Large-scale testing (Phase 3)Study completedNCT03106779What this trial is testingStudy of Efficacy of CML-CP Patients Treated With ABL001 Versus Bosutinib, Previously Treated With 2 or More TKIsWho this might be right forChronic Myelogenous Leukemia Novartis Pharmaceuticals 233
Not applicableLooking for participantsNCT02958462What this trial is testingPre-myeloid Cancer and Bone Marrow Failure Clinic StudyWho this might be right forMyeloid MalignancyInherited Bone Marrow Failure SyndromeClonal Expansion+10 more Mayo Clinic 2,000
Not applicableStudy completedNCT04902833What this trial is testingAcquired Pyruvate Kinase Deficiency In Clonal Myeloid NeoplasmsWho this might be right forPyruvate Kinase DeficiencyPyruvate Kinase Deficiency AnemiaHereditary Hemolytic Anemia+8 more Massachusetts General Hospital 18
Testing effectiveness (Phase 2)Looking for participantsNCT06566742What this trial is testingStudy Evaluating Olutasidenib in Patients With IDH1-mutated Clonal Cytopenia of Undetermined Significance and Lower-risk Myelodysplastic/Syndromes/Chronic Myelomonocytic Leukemia.Who this might be right forMyelodysplastic SyndromesChronic Myelomonocytic LeukemiaClonal Cytopenia of Undetermined Significance M.D. Anderson Cancer Center 15
Not applicableStudy completedNCT00899795What this trial is testingEvaluating Cell Damage in Patients With Acute Myeloid Leukemia, Myelodysplastic Syndromes, or Fanconi Anemia; in Patients Who Were Exposed to Alkylating Agents; and in Healthy VolunteersWho this might be right forLeukemiaMyelodysplastic Syndromes OHSU Knight Cancer Institute 35
Large-scale testing (Phase 3)Active Not RecruitingNCT05456191What this trial is testingInvestigate Tolerability and Efficacy of Asciminib (Oral) Versus Nilotinib (Oral) in Adult Participants (≥18 Years of Age) With Newly Diagnosed Philadelphia Chromosome Positive Chronic Myelogenous Leukemia in Chronic Phase (Ph+ CML-CP)Who this might be right forPhiladelphia Chromosome-Positive Chronic Myeloid Leukemia Novartis Pharmaceuticals 568
Not applicableLooking for participantsNCT05983991What this trial is testingStudy for Characterisation of Predictive Parameters of Clonal Evolution in Subjects With GATA2 Germline MutationWho this might be right forGATA2 Gene Mutation Institut Claudius Regaud 150
Not applicableLooking for participantsNCT06295965What this trial is testingClonal Hematopoiesis and Therapy-Emergent Myeloid Neoplasms in Patients With Cancers, CHANCES StudyWho this might be right forRecurrent Fallopian Tube CarcinomaRecurrent Ovarian CarcinomaRecurrent Primary Peritoneal Carcinoma+7 more University of Washington 2,000
Testing effectiveness (Phase 2)Study completedNCT00782067What this trial is testingEfficacy and Safety of Midostaurin in Patients With Aggressive Systemic Mastocytosis or Mast Cell LeukemiaWho this might be right forLeukemia Novartis Pharmaceuticals 116
Not applicableStudy completedNCT02380222What this trial is testingPatient-Reported Outcome Questionnaire for Systemic MastocytosisWho this might be right forAggressive Systemic Mastocytosis (ASM)SM w Assoc Clonal Hema Non-mast Cell Lineage Disease (SM-AHNMD)Mast Cell Leukemia (MCL)+2 more Adelphi Values LLC 5